Lyra Therapeutics' Series B Round

Lyra Therapeutics raised a round of funding on September 26, 2018.

Lyra Therapeutics, fka 480 Biomedical, is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conve…

Articles about Lyra Therapeutics' Series B Round: